Welcome to DrPHealth

Please leave comments and stimulate dialogue. For those wanting a bit more privacy or information, email drphealth@gmail.com. Comments will be posted unless they promote specific products or services, or contain inappropriate material or wording. Twitter @drphealth.

Sunday 3 June 2012

DrPHealth blog evaluation


As the site passes approaches 7500 views, some statistics for dedicated readers.


Month of May
All-time (11 months)
Posts
15
172
Views
624 (20.1 views per day)
7416 (22.1 views per day)
Canadian viewer proportion
28.7%
62.8%
Other top viewing countries
US – 33.0%
Russia – 11.5%
Other European – 6%
Other - ~21%
US – 17.5%
Russia – 7%
Other European – 5%
Other ~ 8%
Top Posts viewed
Health and Built Environment 3 Health social services May 3  – 41 views
Telehealth (Apr 3) – 32 views in May
Bill C-31 May 7 – 32 views
Opposition to Bill C-31 May 16 -22 views
Cost of poverty Jan12 – 121 views
Telehealth Apr 3 – 106 views
Smart meters Feb 3 -  69 views
Social injustice Dec 5 – 56 views
Determinants Jan 9  – 51 views
Referring sites
Google – 66
Facebook - 3
Google – 189
Twitter – 106
Domar – 70
Linked In – 56
CHNet – 34
Facebook - 32

What conclusions can you draw?  Here are ours:

Canadian readership has either dropped or moved to direct email for which no tracking is available
Issues of social justice seem to have the greatest popularity
Niche topics can be either very successful (Telehealth and healthy built environment), or very disappointing (weather and health series).  (Posting specific information is available for total views)
Canadian specific content which is the focus of the blog is not attracting the attention that was the messaging intent
Twitter and Link-in posting are not nearly as effective as they were
A small handful of 4 or 5 dedicated viewers have provided most of the 26 published comments and dialogue on the drphealth@gmail.com site. 

Your comments, thoughts and suggestions are welcome by posting a comment or sending privately to drphealth@gmail.com

Thank you for your continued readership.  

No comments:

Post a Comment